67
47
Growth Score
-19 pts
Heat Score
-27 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
276929
Stellular Bio develops regenerative biologic therapies for ocular surface diseases using platelet-derived technologies.
- Jonathan Thon: FounderPast Role: mDETECT Inc, Founder and CEO
About the Company
Stellular Bio is a biotechnology company focused on developing innovative therapies for ocular surface diseases. It specializes in the creation of a platelet-derived regenerative biologic (PRB) therapy aimed at enhancing the quality of life for patients suffering from these conditions. The company is also pioneering a platform for producing
allogeneic, stem-cell-derived platelet-like cells (PLCs), which represents a versatile approach in regenerative medicine. Stellular Bio's research and development efforts are dedicated to harnessing the potential of platelet-inspired cell therapy to address unmet medical needs in ophthalmology.
